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Background: Transient white matter lesions have been rarely reported in X-linked Charcot-Marie-Tooth disease type 1.
Case presentation: We describe a 15-year-old boy who presented transient and recurrent weakness of the limbs for
5 days. His mother, his mother’s mother and his mother’s sister presented pes cavus. MRI and electrophysiology were
performed in the proband. Gap junction protein beta l gene was analyzed by PCR-sequencing in the proband and his
parents. The electrophysiological studies showed a mixed demyelinating and axonal sensorimotor neuropathy. MRI
showed white matter lesions in the internal capsule, corpus callosum and periventricular areas, which showed almost
complete resolution after two months. T278G mutation in Gap junction protein beta l gene was detected in the
proband and his mother.
Conclusion: This case report highlights that the novel T278G mutation of Gap junction protein beta l maybe could
result in X-linked Charcot-Marie-Tooth disease type 1 with predominant leucoencephalopathy. The white matter
changes in MRI of X-linked Charcot-Marie-Tooth disease type 1 patient are reversible.
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Charcot-Marie-Tooth disease (CMT) is the most fre-
quent hereditary neurological disorder in the world,
which affects 1 in 2,500 people. Most CMT diseases are
autosomal dominant, the rest are recessive and X-linked
forms. CMTX is divided into a dominant CMTX1 and
four recessive CMTX2–5. CMTX accounts for approxi-
mately 10%-20% of all hereditary demyelinating neurop-
athies [1].
CMTX is characterized by distal muscle weakness
and atrophy with characteristic steppage gait,pes cavus,
decreased deep tendon reflexes and sensory loss. Recently,
transient white matter lesions in CMTX have been re-
ported, and become a prominent clinical manifestation.
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reproduction in any medium, provided the orchromosome Xq13.1 that codes for the connexin 32
protein (Cx32). Cx32 is expressed in the myelinating
Schwann cells of the peripheral nerves. However, the
protein is also widely expressed in the oligodendrocyte of
the central nervous system (CNS). Cx32 maintains the
permeability of myelinating cells [2]. CX32 plays an im-
portant an role in the biology of myelin-forming cells
Cx32 maintains the permeability of neurons. We analyse a
CMTX male patient by the clinical manifestations, imag-
ings and genetic analyses, who developed transient CNS
dysfunction accompanied by a Cx32 mutation and diffuse
white matter abnormalities.
Case presentation
A 15-year-old male of Han nationality presented with a
sudden weakness of limbs. Five days before being ad-
mitted to our hospital, about five pm after school, the
patient felt weakness of the lower limbs and walked un-
steadily. However, he did not show weakness of bothtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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headache, numbness of the limbs, convulsion and in-
continence. About five thirty pm, weakness of his both
lower limbs disappeared. But he showed weakness of
both upper limbs twice. Three days before admission,
he did not write well with his right hand when he was at
school. Two days before admission, he could not lift his
left arm and had slurred speech, dysphagia, which lasted
2–3 hours before being recovered. On the day of admis-
sion, he presented right hemiplegia and numbness. His-
tory of past illness showed that he had a high fever two
weeks before onset, the highest temperature was 39.9°C,
and he was poor in spirit, but did not show cough,
expectoration, sore throat or other symptoms. He was
treated by Ceftriaxone sodium and dexamethasone, and
he got well soon. Two months before onset, he had a
history of lower extremity weakness lasting about 30 mi-
nutes. He was the product of a normal full-term preg-
nancy and delivery. He had no learning difficulties. His
mother, his mother’s mother and his mother’s sister pre-
sented pes cavus.
His medical examination presented the atrophy of his
interosseous muscles and his distal lower extremities,
flat thenar muscles, poor flexibility of his hands, dimin-
ished deep tendon reflexes in all extremities, negative bi-
lateral Babinski signs, positive bilateral Pussep signs and
equinovarus. The internal medicine examination showed
no abnormalities.
His investigations showed normal blood counts and
inflammatory markers, renal, liver, electrolytes, sedimen-
tation rate, blood glucose and thyroid function test. Cere-
brospinal fluid analysis showed mildly elevated white blood
cell (6 × 106/L) and mildly elevated protein (65 mg/dl)
without oligoclonal bands. The first MRI after four days of
onset of symptoms (Figure 1) revealed diffuse signal ab-
normalities in the internal capsule, corpus callosum, peri-
ventricular areas. The second MRI after nine days of onset
(Figure 2) showed no change compared with the first one.Figure 1 The first MRI after four days of onset. Diffusion-weighted MRI
transient weakness of the limbs, slurred speech and dysphagia, shows diffu
callosum (B) and periventricular areas (C). Neurologic examination reveals m
extremities and giving the characteristic inverted champagne bottle appeaThe third MRI after two months (Figure 3) showed almost
complete resolution of the white matter changes.
Electromyogram presented peripheral neurogenic da-
mages of upper and lower extremities (Table 1). BAEP
showed prolongation of latency in bilateral wave III and
wave I-III interpeak, poor reproducibility in Wave V gra-
phics. Somatosensory evoked potential of upper limbs
presented prolongation of latency in bilateral cortical
potential N20 and bilateral subcortical potential N9,
N13. Somatosensory evoked potential of lower limbs re-
vealed prolongation of latency on the right side of the
cortical potential P40, and that graphic differentiation is
not clear on the left cortical potential P40 and bilateral
subcortical potential N21.
Genetic testing of this patient showed a T to G transi-
tion at nucleotide 278 in connexin 32, resulting in chan-
ging a methionine to a arginine. His mother had T278G
heterozygous mutation (Figure 4). His father had normal
sequence.
The patient had normal strength in all muscle groups,
but the deep tendon reflexes were diminished bilaterally
when he was in our department. After hospital discharge,
there was no longer onset of his neurological symptoms.
Conclusion
The patient in this case had hyperpyrexia two weeks
before onset of the disease. The clinical manifestations
showed repeated transient weakness of the limbs, slurred
speech and dysphagia. Neurologic examination revealed
muscular atrophy of distal limbs, diminished deep ten-
don reflexes in all extremities and giving the characteris-
tic inverted champagne bottle appearance. Brain MRI
scans presented white matter abnormalities in the in-
ternal capsule, corpus callosum and periventricular areas.
Two months later,his third brain MRI showed that the sig-
nal abnormalities had almost disappeared. Electrophysi-
ology certified peripheral neuropathy. The genetic analysis
showed a pathogenic mutation in GJB1. This patient wasafter four days of the onset of symptoms, which presents repeated
se signal abnormalities in the internal capsule (A and B), corpus
usclar atrophy of distal limbs, diminished deep tendon reflexes in all
rance.
Figure 2 The second MRI after nine days of onset. Diffusion-weighted MRI afternine days of the onset of symptoms shows no change
compared with the first MRI (A, B and C).
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ent white matter abnormalities.
CMT is classified as autosomal dominant, autosomal
recessive or X-linked CMT (CMTX). CMTX is divided
into a dominant CMTX1 and four recessive CMTX 2–5
[3]. At present we think that CMTX1 is caused by muta-
tion in the GJB1 gene on chromosome Xq13.1 at codes
for the connexin 32 protein (Cx32). Cx32 is expressed in
myelinating Schwann cells and localized to paranodal
regions and Schmidt Lanternmann incisures. Six con-
nexins oligomerize to form hemichannels or connexons.
When properly opposed to each other on cell mem-
branes, two connexons form gap junction channels that
permit the diffusion of ions and small molecules [4].
The diffusion of ions and small molecules may be re-
stricted by Cx32 mutation, which causes the defect of
nervous functions.
Case reports show that transient cerebral white matter
lesions of CMXT1 can be acute or subacute ataxia, dys-
arthria, hypoesthesia, aphasia, hemiplegia or quadriplegia
etc., which can be alleviated in several hours or several
days, or maybe attack repeatedly. Usually the CMXT1
symptoms are severe in male patients, but asymptomatic
or mild in female carriers [5]. Although there are re-
ports of some female heterozygotes who have serious
manifestations [6].Figure 3 The third MRI after two mouths of onset. Diffusion-weighted
peated neurological attracks, shows nearly complete resolution of the whitPredisposing factors to transient cerebral white matter
lesions of CMXT1 may be return to plain from high alti-
tude area, fever, infection, can even be no clear reason
[4,7–10]. The CMTX1 typical MRI shows abnormalities
in non-enhanced, confluent, symmetrical corpus callo-
sum and periventricular white matter [5]. These episodes
may be related to temporary myelin vacuolation as sug-
gested by restricted diffusion in the affected areas on
MRI. Using transgenic mice shows that the mutation of
Cx32 loses its function in Schwann cells and oligoden-
drocytes, resulting in myelination defects of the periph-
eral and central nervous system [11]. Dysfunctional gap
junctions as a result of the mutation enables these cells
have no ability to adjust fluid exchange, these could ex-
plain the restricted diffusion on MRI [9]. Follow-ups and
literature reports about cerebral white matter lesions
present that brain MRI can be fully recovered or im-
proved in hours, days or months.
This paper reports the electrophysiological examin-
ation of the patient, which presents that the peripheral
nerve axon and myelin sheath are involved. It is also re-
ported previously that axon and myelin sheath can be
involved at the same time [6], or the axon is involved
mainly [12].
The male patient with novel T278G mutation of
GJB1 had hemizygous, and his mother had heterozygousMRI after two months of onset by which time the patient has no re-
e matter changes (A, B and C).
Table 1 Nerve conduction studies
Nerve Stimulation site Distal latency (ms) Amplitude (sensory in μV, motor in mV) Velocity (m/s)
Sensory
Left median Finger I 3.2 (↓92%) 33 (↓42%)
Wrist 3.7 (↓69%) 43 (↓39%)
Right median Finger I 1.3 (↓97%) 37 (↓35%)
Wrist 2.7 (↓78%) 42 (↓40%)
Right ulnar Finger V 1.8 (↓89%) 36 (↓39%)
Wrist 2.0 (↓78%) 45 (↓33%)
Left fibular Toe I Absent
Ankle Absent
Left posterior tibial Toe I Absent
Right fibular Toe I Absent
Ankle Absent
Right posterior tibial Toe I Absent
Motor
Left median Wrist 4.2 (↑40%) 1.7 (↓92%)
Elbow 1.5 (↓91%) 40 (↓38%)
Right median Wrist 4.0 (↑33%) 7.7 (↓65%)
Elbow 5.0 (↓72%) 33 (↓49%)
Right ulnar Wrist 2.7 (Normal) 8.9 (Normal)
Elbow 7.7 (Normal) 39 (↓39%)
Left fibular Ankle Absent
Fibular head Absent
Left posterior tibial Ankle 4.5 (Normal) 0.3 (↓98%)
Right fibular Ankle Absent
Fibular head Absent
Right posterior tibial Ankle Absent
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ther’s sister presented pes cavus. His father had normal se-
quence. The CMTX1 has been known to be an X-linked
dominant inheritance pattern. In CMTX, male patients
tend to be severely affected, and females are generally
asymptomatic [6]. The GJBl mutation in the male patientFigure 4 Chromatograms of a Cx32 mutation. The arrow in chromatog
in the male Chinese patient with X-linked Charcot-Marie-Tooth disease. The a
mutation in the patient’s mother.results in the change of met93arg. We speculate that the
mutation may lead to loss of functional gap junction pro-
tein in Schwann cells and oligodendrocytes, which causes
the dysfunction in central nervous system.
We reported a T278G mutation causing a methionine
to arginine substitution on code 93 (M93A). Bell et al.ram A represents the mutation site (T to G transition at nucleotide 278)
rrow in chromatogram B represents the site of a T278G heterozygous
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Both mutations affected the same amino acid (methio-
nine). The clinical manifestations of M93V included
tremor, spasticity, brisk reflexes and extensor plantar re-
sponses. On MRI there was atrophy of the cerebral cortex
and cerebellum. While the phenotype of M93A presented
transient and recurrent weakness of the limbs and dimin-
ished deep tendon reflexes in all extremities. MRI showed
reversibility white matter lesions in the internal capsule,
corpus callosum and periventricular areas.
In conclusion, T278G is a new mutation in the GJBl
gene, which may be associated with CMTX1. The disease
shows paroxysmal leukoencephalopathy. Axonal and mye-
lin lesions result in weakness of limbs, slurred speech,
swallowing difficulties. Reversible cerebral white matter
damages of corpus callosum and periventricular areas are
the characteristics of the disease on MRI. For patients who
have peripheral nerve damages and reversible cerebral
white matter degeneration, CMTX1 should be considered.
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